Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer N Clements

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
A Possible Case of Gabapentin-Induced Mild HyperglycemiaJennifer Andres, Jennifer N Clements, Donna Salmiery
Journal of Pharmacy Practice|October 6, 2017
Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With GoutEmily Huneycutt, Chase Board, Jennifer N Clements
Touchreviews in Endocrinology|November 17, 2025
A Clinical Review of Continuous Glucose Monitoring in the Hospital SettingJennifer N Clements, Kennedy Howard, Emory Moss
Journal of Pharmacy Practice|August 14, 2016
Drug-Induced Vitamin B<sub>12</sub> Deficiency: A Focus on Proton Pump Inhibitors and Histamine-2 AntagonistsLauren Linder, Cynthia Tamboue, Jennifer N Clements
Pharmacotherapy|February 16, 2026
Current and Emerging Pharmacologic Therapies for Diabetic RetinopathyJennifer N Clements, Julia Mesawich, Cassandra Twisdale
Clinical Pharmacokinetics|June 20, 2018
Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor AgonistSylvie Hall, Diana Isaacs, Jennifer N Clements
Clinical Pharmacokinetics|July 7, 2018
Faster Insulin Aspart: A New Bolus Option for Diabetes MellitusAbigayle Davis, Jolly Kuriakose, Jennifer N Clements
Expert Review of Endocrinology & Metabolism|July 31, 2018
Liraglutide, GLP-1 receptor agonist, for chronic weight lossKatherine G Moore, Kayce Shealy, Jennifer N Clements
The Mental Health Clinician|June 30, 2018
What's new in multiple sclerosis?Erika E Tillery, Jennifer N Clements, Zach Howard
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 24, 2019
Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to dateRebecca Howell, Adrienne M Wright, Jennifer N Clements
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
A Possible Case of Gabapentin-Induced Mild HyperglycemiaJennifer Andres, Jennifer N Clements, Donna Salmiery
Journal of Pharmacy Practice|October 6, 2017
Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With GoutEmily Huneycutt, Chase Board, Jennifer N Clements
Touchreviews in Endocrinology|November 17, 2025
A Clinical Review of Continuous Glucose Monitoring in the Hospital SettingJennifer N Clements, Kennedy Howard, Emory Moss
Journal of Pharmacy Practice|August 14, 2016
Drug-Induced Vitamin B<sub>12</sub> Deficiency: A Focus on Proton Pump Inhibitors and Histamine-2 AntagonistsLauren Linder, Cynthia Tamboue, Jennifer N Clements
Pharmacotherapy|February 16, 2026
Current and Emerging Pharmacologic Therapies for Diabetic RetinopathyJennifer N Clements, Julia Mesawich, Cassandra Twisdale
Clinical Pharmacokinetics|June 20, 2018
Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor AgonistSylvie Hall, Diana Isaacs, Jennifer N Clements
Clinical Pharmacokinetics|July 7, 2018
Faster Insulin Aspart: A New Bolus Option for Diabetes MellitusAbigayle Davis, Jolly Kuriakose, Jennifer N Clements
Expert Review of Endocrinology & Metabolism|July 31, 2018
Liraglutide, GLP-1 receptor agonist, for chronic weight lossKatherine G Moore, Kayce Shealy, Jennifer N Clements
The Mental Health Clinician|June 30, 2018
What's new in multiple sclerosis?Erika E Tillery, Jennifer N Clements, Zach Howard
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 24, 2019
Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to dateRebecca Howell, Adrienne M Wright, Jennifer N Clements
Pageof 4